- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有14家主力机构披露2025-12-31报告期持股数据，持仓量总计3394.90万股，占流通A股2.40%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为17.46元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"17.46","date":1770105695,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.02.04","stock":"2.61","trade":"0.70","ind":"0.21"},{"date":"2026.02.03","stock":"1.23","trade":"1.66","ind":"2.19"},{"date":"2026.02.02","stock":"-2.07","trade":"-2.66","ind":"-2.69"},{"date":"2026.01.30","stock":"-3.45","trade":"-1.26","ind":"-0.66"},{"date":"2026.01.29","stock":"0.73","trade":"-1.58","ind":"-0.30"},{"date":"2026.01.28","stock":"-4.18","trade":"-2.31","ind":"0.09"},{"date":"2026.01.27","stock":"-6.10","trade":"-0.80","ind":"0.09"},{"date":"2026.01.26","stock":"14.87","trade":"3.60","ind":"-0.85"},{"date":"2026.01.23","stock":"1.47","trade":"1.33","ind":"0.79"},{"date":"2026.01.22","stock":"0.47","trade":"-0.59","ind":"0.50"},{"date":"2026.01.21","stock":"-0.82","trade":"0.19","ind":"0.70"},{"date":"2026.01.20","stock":"-2.68","trade":"-0.83","ind":"-0.97"},{"date":"2026.01.19","stock":"-7.19","trade":"0.05","ind":"0.09"},{"date":"2026.01.16","stock":"-2.57","trade":"-0.86","ind":"-0.18"},{"date":"2026.01.15","stock":"-3.05","trade":"-1.14","ind":"0.41"},{"date":"2026.01.14","stock":"-0.79","trade":"-0.57","ind":"0.56"},{"date":"2026.01.13","stock":"0.55","trade":"2.27","ind":"-1.37"},{"date":"2026.01.12","stock":"1.41","trade":"0.29","ind":"1.75"},{"date":"2026.01.09","stock":"1.69","trade":"2.11","ind":"1.15"},{"date":"2026.01.08","stock":"0.72","trade":"0.71","ind":"-0.51"},{"date":"2026.01.07","stock":"-1.07","trade":"1.05","ind":"0.06"}]
智飞生物,深证成指,生物制品指数
压力支撑
该股压力位为17.39元，支撑位为16.98元。
[{"text":"\u538b\u529b\u4f4d","value":"17.39","date":1770134400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"16.98","date":1770134400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.8资金面打败了7%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：02月04日 20:30
| 机构今日流向(万元) | 440.71 | 机构5日流向(万元) | -7535.73 |
| 机构10日流向(万元) | -11808.16 | 机构20日流向(万元) | -24602.60 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少25428.83万股，其中基金净增仓2家，主力净减仓380家，暂未发现中长期投资价值。
截止2025-12-31，共14家主力机构（基金14家），持仓量总计3394.9万股，占流通A股2.40%
其中，基金持仓与2025-06-30相比：
增仓：8家 ，增持 93.66万股
减仓：6家 ，减持 274.84万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：380家 ，原持有25247.65万股
其中，基金持仓与2025-06-30相比：
增仓：8家 ，增持 93.66万股
减仓：6家 ，减持 274.84万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：380家 ，原持有25247.65万股
消息面诊股
诊断结果：4.4消息面打败了18%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 智飞生物：冻干水痘灭活疫苗获得临床试验批准通知书
2026-02-04 - 医药产业迈入2.0时代，医药ETF易方达涨1.06
2026-02-04 - 重要公告速递： 凯龙高科拟购买金旺达70%股权
2026-02-04 - 医药板块景气修复，超270家预告业绩，超三成预增
2026-02-03 - 智飞生物：带状疱疹mRNA疫苗获临床试验批准
2026-02-03 - 业绩分化加剧！A股137家生物医药上市公司预亏
2026-02-02 - 近3000家公司“交卷”，A股2025年业绩预告收
2026-02-02 - 需求退潮、库存压顶，疫苗“三巨头”打响生存战
2026-02-02 - 国内卖不动的疫苗，出口海外卖爆了
2026-02-02 - 价格战持续，疫苗行业2025年业绩分化加剧
2026-02-02
消息列表
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-12 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-05 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-18 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-30 |
| 一般消息 | 高管变动 | 因公司治理结构及内部工作调整 | 2025-10-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-20 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：5.5行业面打败了73%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.02.04","price":"0.21","value":"0.70"},{"date":"2026.02.03","price":"2.19","value":"1.66"},{"date":"2026.02.02","price":"-2.69","value":"-2.66"},{"date":"2026.01.30","price":"-0.66","value":"-1.26"},{"date":"2026.01.29","price":"-0.30","value":"-1.58"},{"date":"2026.01.28","price":"0.09","value":"-2.31"},{"date":"2026.01.27","price":"0.09","value":"-0.80"},{"date":"2026.01.26","price":"-0.85","value":"3.60"},{"date":"2026.01.23","price":"0.79","value":"1.33"},{"date":"2026.01.22","price":"0.50","value":"-0.59"},{"date":"2026.01.21","price":"0.70","value":"0.19"},{"date":"2026.01.20","price":"-0.97","value":"-0.83"},{"date":"2026.01.19","price":"0.09","value":"0.05"},{"date":"2026.01.16","price":"-0.18","value":"-0.86"},{"date":"2026.01.15","price":"0.41","value":"-1.14"},{"date":"2026.01.14","price":"0.56","value":"-0.57"},{"date":"2026.01.13","price":"-1.37","value":"2.27"},{"date":"2026.01.12","price":"1.75","value":"0.29"},{"date":"2026.01.09","price":"1.15","value":"2.11"},{"date":"2026.01.08","price":"-0.51","value":"0.71"},{"date":"2026.01.07","price":"0.06","value":"1.05"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万泽股份 | 48.42% | 0.23% | 6.4分 |
| 2 | - | 25.08% | 0.91% | 分 |
| 3 | 卫光生物 | 18.61% | 6.85% | 6.0分 |
| 4 | 华兰疫苗 | 12.99% | -12.59% | 5.3分 |
| 5 | 沃森生物 | 12.98% | -2.53% | 5.2分 |
| 6 | 荣昌生物 | 12.67% | 0.30% | 5.6分 |
| 8 | *ST四环 | 8.64% | 0.38% | 6.2分 |
| 10 | 优宁维 | 7.70% | 1.75% | 5.3分 |
| 12 | 义翘神州 | 4.76% | -2.55% | 4.1分 |
| 14 | 通化东宝 | 3.20% | -3.23% | 4.8分 |
| 16 | 康泰生物 | 2.48% | -2.85% | 5.0分 |
| 18 | 昊帆生物 | 1.81% | -4.57% | 4.6分 |
| 20 | 华兰生物 | 1.36% | -1.14% | 5.6分 |
| 22 | 安科生物 | 0.10% | -3.46% | 5.0分 |
| 24 | 博晖创新 | -0.47% | -11.97% | 3.9分 |
| 26 | 诺诚健华 | -0.65% | 5.49% | 5.9分 |
| 28 | 上海莱士 | -1.09% | -0.31% | 5.1分 |
| 30 | 天坛生物 | -1.73% | -1.32% | 4.7分 |
| 32 | 智翔金泰 | -1.99% | -4.88% | 4.4分 |
| 34 | 博雅生物 | -3.07% | -2.44% | 3.9分 |
| 36 | 长春高新 | -4.05% | -6.15% | 3.4分 |
| 38 | 甘李药业 | -4.17% | -1.71% | 4.8分 |
| 40 | 西藏药业 | -4.72% | -1.66% | 5.2分 |
| 42 | - | -5.86% | 3.65% | 分 |
| 44 | 君实生物 | -6.32% | -9.62% | 4.8分 |
| 46 | 智飞生物 | -8.59% | -1.06% | 5.1分 |
| 48 | 科兴制药 | -9.20% | -8.54% | 4.1分 |
| 50 | 特宝生物 | -13.72% | -4.80% | 4.2分 |
| 52 | 欧林生物 | -15.22% | -5.06% | 4.5分 |
| 54 | 神州细胞 | -16.49% | -9.48% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 44/71 ， 50/71。
[{"date":"2025-09-30","value":"-4.01","vol":"-9.78"},{"date":"2025-06-30","value":"-1.96","vol":"-0.61"},{"date":"2025-03-31","value":"-0.99","vol":"0.46"},{"date":"2024-12-31","value":"6.48","vol":"-0.68"},{"date":"2024-09-30","value":"6.83","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-4.01 | -1.96 | -0.99 | 6.48 | 6.83 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"23.77","vol":"67.61"},{"date":"2025-06-30","value":"28.34","vol":"68.28"},{"date":"2025-03-31","value":"32.19","vol":"68.43"},{"date":"2024-12-31","value":"27.38","vol":"69.85"},{"date":"2024-09-30","value":"27.23","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
23.77 | 28.34 | 32.19 | 27.38 | 27.23 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 52/71 ， 47/71。
[{"date":"2025-09-30","value":"-66.53","vol":"45.25"},{"date":"2025-06-30","value":"-73.06","vol":"6902.04"},{"date":"2025-03-31","value":"-79.16","vol":"6125.27"},{"date":"2024-12-31","value":"-50.74","vol":"47.35"},{"date":"2024-09-30","value":"-41.98","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-66.53 | -73.06 | -79.16 | -50.74 | -41.98 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-156.86","vol":"44.80"},{"date":"2025-06-30","value":"-126.72","vol":"5.44"},{"date":"2025-03-31","value":"-120.93","vol":"-8.46"},{"date":"2024-12-31","value":"-74.99","vol":"-9.81"},{"date":"2024-09-30","value":"-67.07","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-156.86 | -126.72 | -120.93 | -74.99 | -67.07 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，两项指标的行业排名分别为 34/71 ， 47/71。
[{"date":"2025-09-30","value":"0.16","vol":"0.22"},{"date":"2025-06-30","value":"0.10","vol":"0.14"},{"date":"2025-03-31","value":"0.05","vol":"0.06"},{"date":"2024-12-31","value":"0.52","vol":"0.29"},{"date":"2024-09-30","value":"0.44","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.10 | 0.05 | 0.52 | 0.44 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.27","vol":"0.92"},{"date":"2025-06-30","value":"0.16","vol":"0.56"},{"date":"2025-03-31","value":"0.07","vol":"0.26"},{"date":"2024-12-31","value":"1.21","vol":"1.17"},{"date":"2024-09-30","value":"1.12","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.27 | 0.16 | 0.07 | 1.21 | 1.12 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"52.46","vol":"1.84"},{"date":"2025-06-30","value":"49.52","vol":"-1377.61"},{"date":"2025-03-31","value":"12.81","vol":"-46.99"},{"date":"2024-12-31","value":"-41.09","vol":"-11.33"},{"date":"2024-09-30","value":"-60.90","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 52.46 | 49.52 | 12.81 | -41.09 | -60.90 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.00","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.30","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.00 | - | 2.30 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 11/71 ， 7/71。
[{"date":"2025-09-30","value":"2.80","vol":"6.00"},{"date":"2025-06-30","value":"2.45","vol":"6.64"},{"date":"2025-03-31","value":"2.30","vol":"7.75"},{"date":"2024-12-31","value":"2.24","vol":"6.72"},{"date":"2024-09-30","value":"2.10","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.80 | 2.45 | 2.30 | 2.24 | 2.10 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.23","vol":"4.84"},{"date":"2025-06-30","value":"1.06","vol":"5.30"},{"date":"2025-03-31","value":"1.03","vol":"6.35"},{"date":"2024-12-31","value":"1.03","vol":"5.40"},{"date":"2024-09-30","value":"1.14","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.23 | 1.06 | 1.03 | 1.03 | 1.14 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 11/71 ， 14/71。
[{"date":"2025-09-30","value":"36.18","vol":"28.18"},{"date":"2025-06-30","value":"34.18","vol":"26.73"},{"date":"2025-03-31","value":"36.85","vol":"26.03"},{"date":"2024-12-31","value":"38.23","vol":"25.81"},{"date":"2024-09-30","value":"41.46","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
36.18 | 34.18 | 36.85 | 38.23 | 41.46 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.57","vol":"0.58"},{"date":"2025-06-30","value":"0.52","vol":"1.11"},{"date":"2025-03-31","value":"0.58","vol":"0.78"},{"date":"2024-12-31","value":"0.62","vol":"0.87"},{"date":"2024-09-30","value":"0.71","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.57 | 0.52 | 0.58 | 0.62 | 0.71 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"102.09","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"75.39","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"80.70","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"20.18","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.87","blueLineValue":"0.12","type":"YC"}]